None listed
Conditions
Brief summary
Background: Bowel cancer is the most common cancer affecting both men and women. Survivors are at risk of cancer recurrence and a range of physical, emotional, psychological and practical consequences. Follow up inadequately addresses many issues. This study will evaluate an innovative program comprising individualised information, a nurse-led end of treatment consultation and telephone follow up for people with potentially curative bowel cancer, aiming to reduce psychological distress and unmet needs. Aim: To examine the effectiveness of an innovative supportive care program (SurvivorCare) comprising survivorship educational materials, provision of a tailored survivorship care plan, an individually tailored nurse-led end of treatment consultation and telephone follow up for people with potentially curative colorectal cancer, aiming to reduce psychological distress and unmet needs, using a randomised controlled trial.
Interventions
A nurse-led supportive care program (SurvivorCare) comprising:
1) Survivorship educational materials (includes a survivorship DVD and booklet) 2) Provision of a tailored survivorship care plan
3) An individually tailored one-on-one end of treatment consultation with a trained nurse consultant. Session will occur within 2 weeks of treatment completion and duration is 60-90 minutes.
4) Nurse-led telephone follow up for people with potentially curative colorectal cancer, aiming to reduce psycholog
A nurse-led supportive care program (SurvivorCare) comprising: 1) Survivorship educational materials (includes a survivorship DVD and booklet) 2) Provision of a tailored survivorship care plan 3) An individually tailored one-on-one end of treatment consultation with a trained nurse consultant. Session will occur within 2 weeks of treatment completion and duration is 60-90 minutes. 4) Nurse-led telephone follow up for people with potentially curative colorectal cancer, aiming to reduce psychological distress and unmet needs. The telephone follow up will occur at 1, 3, and 7 weeks after the end of treatment session
Sponsors
Victorian Cancer Agency
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Inclusion criteria are that the patient: (1) has a confirmed diagnosis of colon or rectal cancer; (2) has stage I-III disease (i.e. non metastatic); (3) is being treated with curative intent with surgery +/- radiation +/- chemotherapy; (4) is over 18 years; and (5) is able to understand English.
Exclusion criteria
Exclusion criteria are that the person (1) has demonstrated cognitive or psychological difficulties that would preclude study participation; (2) is too unwell to participate in the study.
Outcome results
None listed